The first subtype of the Hallervorden-Spatz syndrome, identified by the mutation in the PANK2 gene and specific radiological and clinical findings, was denominated pantothenate kinase-associated neurodegeneration or PKAN.9 This evidence concerns the gene PANK2 and pantothenate kinase-associated neurodegeneration.